跳至主要内容
临床试验/NCT02800980
NCT02800980Unknown不适用

Management of Symptomatic Post-operative Lymphocele With an Patient-controlled, Vascular Catheter: A Validation Study

Maciej Stukan, MD, PhD1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2016年6月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
Number of patients with successful lymphocele treatment.

研究概览

简要总结

Symptomatic lymphocele (LC) can be a complication after pelvic and para-aortic lymphadenectomy performed for treatment or staging purposes in the management of some cancers. Management procedures are: single or repeated puncture, prolonged drainage with drains or catheters, mostly followed by sclerotherapy, or surgery. A decision, which management option is most optimal, should be guided by two principles: first to control patient's symptoms, second to apply the least invasive but effective way to treat LC, taking into account that the patient has undergone major surgery recently, and often needs adjuvant treatment at the moment when symptomatic LC is diagnosed.

The aim of this study is to validate feasibility, safety and efficacy of a minimally invasive management of a symptomatic LC - drainage with the usage of vascular catheter followed by sclerotherapy, as well as to evaluate patient's experience on the treatment.

Patients with symptomatic LC are evaluated with ultrasound. Data about diameters, estimated volume of LC and other organs failure if appear is recorded. Management options are discussed with patient, and if the method with catheter insertion and drainage is chosen than the patient is eligible for the study. After vascular catheter insertion into LC and fluid evacuation, patient is followed with active drainage. Patients with drainage only are observed for a short period of time (up to 7 days), and if not efficient a sclerotherapy is considered. In case a patient does not agree to sclerotherapy, or there are contraindications, or it is doctor's decision that drainage alone is sufficient, than the prolonged drainage without sclerotherapy is the only procedure. The choice about the regimen used for sclerotherapy, it's volume, time intervals between repeated infusion depend on institution practice.

Data concerning feasibility, safety and efficacy are noted in designated templates. Patients' experience on the treatment is evaluated with formal questionnaire FACIT-TS-G.

The study is observational. Primary outcome measure is to establish efficacy of the method. Secondary outcome measures are safety and patient's experience on the treatment.

Investigators hope to establish step-by-step guidelines for optimal, minimally invasive management of symptomatic lymphocele.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • symptomatic lymphocele after abdominal lymphadenectomy for cancer,
  • age > 18 years old,
  • informed consent signed,

排除标准

  • asymptomatic lymphocele,
  • apparent infection of the skin or subcutaneus tissue over the lymphocele (in the place of potential catheter insertion),
  • significant coagulopathy

结局指标

主要结局

Number of patients with successful lymphocele treatment.

时间窗: 2 months

Successful lymphocele treatment means complete resolution of lymphocele after minimally invasive procedures - percutaneous drainage with a vascular catheter followed by sclerotherapy or drainage alone. Opposite - non successful treatment defined when the patient is refered for a surgical management.

次要结局

  • Number of adverse events concerned with catheter insertion.(2 months)
  • Number of adverse events concerned with sclerotherapy.(2 months)
  • Number of successful catheter insertion into lymphocele lumen.(1 day)

研究者

发起方
Maciej Stukan, MD, PhD
申办方类型
Other Gov
责任方
Sponsor Investigator
主要研究者

Maciej Stukan, MD, PhD

Dr

Gdynia Oncology Center

研究点 (1)

Loading locations...

相似试验